Stoke Therapeutics stockSTOK
Stoke Therapeutics trades at $26.07, 35.2% below its 52-week high (Mar 10, 2026). The price is below its 50- and 200-day averages, a downtrend. −17.9% year to date, +14.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 16, 2027.
Ratings, candles, signals and the screener for STOK — after you log in
Open the terminalFrequently asked questions about Stoke Therapeutics
What is the Stoke Therapeutics stock price?
At the close on Nov 5, 2026: $26.07 (−5.03% on the day). 52-week high: $40.22 on Mar 10, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Stoke Therapeutics report earnings?
The next quarterly report is on Mar 16, 2027. Last quarter, earnings per share changed −66% year over year, revenue +6%.
Does Stoke Therapeutics pay dividends?
No, Stoke Therapeutics does not pay dividends.
Where does Stoke Therapeutics trade and how to buy it?
Ticker STOK, exchange Nasdaq, listed since 2019. You can buy it through a broker with access to US exchanges.
Should I buy Stoke Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for STOK are in the terminal after you log in.